中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
15期
20-21
,共2页
临床效果%联合化疗%米托蒽醌%氟达拉滨
臨床效果%聯閤化療%米託蒽醌%氟達拉濱
림상효과%연합화료%미탁은곤%불체랍빈
Clinical effect%Combined Chemotherapy%Mitoxantrone%Fludarabine
目的:探析恶性淋巴瘤应用氟达拉滨联合米托蒽醌(FND)与CHOP方案治疗的临床效果对比。方法入选该院恶性淋巴瘤患者64例,随机分为两组各32例,观察组进行FND化疗方案,对照组施行CHOP化疗方案,比较两组的临床效果及化疗方案副反应。结果观察组的临床总有效率显著高于对照组(P<0.05),观察组不良反应主要以骨髓抑制为主,对照组的主要副反应是消化道不适,观察组的化疗方案不良反应显著低于对照组(P<0.05)。结论恶性淋巴瘤施行氟达拉滨联合米托蒽醌化疗方案,临床效果确切,化疗不良反应可以耐受,可靠安全,值得临床推广。
目的:探析噁性淋巴瘤應用氟達拉濱聯閤米託蒽醌(FND)與CHOP方案治療的臨床效果對比。方法入選該院噁性淋巴瘤患者64例,隨機分為兩組各32例,觀察組進行FND化療方案,對照組施行CHOP化療方案,比較兩組的臨床效果及化療方案副反應。結果觀察組的臨床總有效率顯著高于對照組(P<0.05),觀察組不良反應主要以骨髓抑製為主,對照組的主要副反應是消化道不適,觀察組的化療方案不良反應顯著低于對照組(P<0.05)。結論噁性淋巴瘤施行氟達拉濱聯閤米託蒽醌化療方案,臨床效果確切,化療不良反應可以耐受,可靠安全,值得臨床推廣。
목적:탐석악성림파류응용불체랍빈연합미탁은곤(FND)여CHOP방안치료적림상효과대비。방법입선해원악성림파류환자64례,수궤분위량조각32례,관찰조진행FND화료방안,대조조시행CHOP화료방안,비교량조적림상효과급화료방안부반응。결과관찰조적림상총유효솔현저고우대조조(P<0.05),관찰조불량반응주요이골수억제위주,대조조적주요부반응시소화도불괄,관찰조적화료방안불량반응현저저우대조조(P<0.05)。결론악성림파류시행불체랍빈연합미탁은곤화료방안,림상효과학절,화료불량반응가이내수,가고안전,치득림상추엄。
Objective To compare the clinical effect between fludarabine combined with mitoxantrone (FDN) and CHOP scheme for the treatment of ML. Methods 64 cases of patients with ML admitted in our hospital were selected and randomly divided into 2 groups, both with 32 cases. The observation group was given FND chemotherapy scheme while the control group was given CHOP chemotherapy. The clinical effects and side effects of the 2 groups were compared. Results The total effective rate of the observa-tion group was obviously higher than that of the control group (P<0.05). Adverse reactions of the observation group was mainly myelosuppression while that of the control group was mainly digestive discomfort. Adverse reactions of observation group were ob-viously fewer than those of control group (P<0.05). Conclusion FDN chemotherapy scheme for the treatment of ML has accurate clinical effects and tolerable side effects. It's safe and reliable and worthy of being popularized in clinical work.